Home : Alpha Glucosidase Inhibitors Market to record USD 567.96 Mn incremental growth -- Driven by increase in awareness of diabetes and growing initiatives |
|
Sep 26 2022 |
Alpha Glucosidase Inhibitors Market to record USD 567.96 Mn incremental growth -- Driven by increase in awareness of diabetes and growing initiatives |
NEW YORK, Sept. 26, 2022 /PRNewswire/ -- The "Alpha Glucosidase Inhibitors Market by Disease Type and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune... |
|
|
Source:https://www.prnewswire.com:443/news-releases/alpha-glucosidase-inhibitors-market-to-record-usd-567-96-mn-incremental-growth--driven-by-increase-in-awareness-of-diabetes-and-growing-initiatives-301632046.html |
|
Related News
|
» XNK Therapeutics to use generic name evencaleucel for lead candidate » Castellum is among the first to receive NollCO2 certification |